These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32754110)

  • 21. Effect of low-dose temazepam on physiological variables and performance tests following a westerly flight across five time zones.
    Reilly T; Atkinson G; Budgett R
    Int J Sports Med; 2001 Apr; 22(3):166-74. PubMed ID: 11354518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of SM-1 in a transient insomnia model.
    Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies.
    Leger D; Quera-Salva MA; Vecchierini MF; Ogrizek P; Perry CA; Dressman MA
    Expert Opin Drug Saf; 2015; 14(11):1673-85. PubMed ID: 26393492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
    JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of melatonin in circadian rhythm disorders and following phase shifts.
    Skene DJ; Deacon S; Arendt J
    Acta Neurobiol Exp (Wars); 1996; 56(1):359-62. PubMed ID: 8787196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jet Lag and Shift Work Disorder.
    Reid KJ; Abbott SM
    Sleep Med Clin; 2015 Dec; 10(4):523-35. PubMed ID: 26568127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase-dependent effect of room light exposure in a 5-h advance of the sleep-wake cycle: implications for jet lag.
    Boivin DB; James FO
    J Biol Rhythms; 2002 Jun; 17(3):266-76. PubMed ID: 12054198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zolpidem reduces the sleep disturbance of jet lag.
    Jamieson AO; Zammit GK; Rosenberg RS; Davis JR; Walsh JK
    Sleep Med; 2001 Sep; 2(5):423-30. PubMed ID: 14592392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tasimelteon: a selective and unique receptor binding profile.
    Lavedan C; Forsberg M; Gentile AJ
    Neuropharmacology; 2015 Apr; 91():142-7. PubMed ID: 25534555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
    Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
    J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology of jet lag.
    Sack RL
    Travel Med Infect Dis; 2009 Mar; 7(2):102-10. PubMed ID: 19237143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder.
    Gumenyuk V; Roth T; Drake CL
    Chronobiol Int; 2012 Aug; 29(7):928-36. PubMed ID: 22823876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial bright light and symptoms of jet lag: a randomized, placebo-controlled trial.
    Jurvelin H; Jokelainen J; Takala T
    Aerosp Med Hum Perform; 2015 Apr; 86(4):344-50. PubMed ID: 25945550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tasimelteon safely and effectively improves sleep in Smith-Magenis syndrome: a double-blind randomized trial followed by an open-label extension.
    Polymeropoulos CM; Brooks J; Czeisler EL; Fisher MA; Gibson MM; Kite K; Smieszek SP; Xiao C; Elsea SH; Birznieks G; Polymeropoulos MH
    Genet Med; 2021 Dec; 23(12):2426-2432. PubMed ID: 34316024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults.
    Richardson GS; Zee PC; Wang-Weigand S; Rodriguez L; Peng X
    J Clin Sleep Med; 2008 Oct; 4(5):456-61. PubMed ID: 18853704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light.
    Revell VL; Burgess HJ; Gazda CJ; Smith MR; Fogg LF; Eastman CI
    J Clin Endocrinol Metab; 2006 Jan; 91(1):54-9. PubMed ID: 16263827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of consecutive transmeridian flights on alertness, sleep-wake cycles and sleepiness: A case study.
    Gordon CJ; Comas M; Postnova S; Miller CB; Roy D; J Bartlett D; R Grunstein R
    Chronobiol Int; 2018 Oct; 35(11):1471-1480. PubMed ID: 29993295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase advancing human circadian rhythms with morning bright light, afternoon melatonin, and gradually shifted sleep: can we reduce morning bright-light duration?
    Crowley SJ; Eastman CI
    Sleep Med; 2015 Feb; 16(2):288-97. PubMed ID: 25620199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.